Search details
1.
Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial.
Brain
; 146(2): 461-474, 2023 02 13.
Article
in English
| MEDLINE | ID: mdl-36256599
2.
A phase I dose-escalation study of the safety and pharmacokinetics of a tablet formulation of voxtalisib, a phosphoinositide 3-kinase inhibitor, in patients with solid tumors.
Invest New Drugs
; 36(1): 36-44, 2018 02.
Article
in English
| MEDLINE | ID: mdl-28417284
3.
Phase I dose-escalation study of cabazitaxel administered in combination with cisplatin in patients with advanced solid tumors.
Invest New Drugs
; 32(6): 1236-45, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25117475
4.
Local gene transfer and expression following intramuscular administration of FGF-1 plasmid DNA in patients with critical limb ischemia.
Mol Ther
; 17(5): 914-21, 2009 May.
Article
in English
| MEDLINE | ID: mdl-19240689
5.
Phase I safety and pharmacokinetic dose-escalation study of pilaralisib polymorph E, a phosphoinositide 3-kinase inhibitor in tablet formulation, in patients with solid tumors or lymphoma.
Cancer Chemother Pharmacol
; 78(1): 83-90, 2016 Jul.
Article
in English
| MEDLINE | ID: mdl-27169794
6.
Gene transfer of a chimeric trans-activator is immunogenic and results in short-lived transgene expression.
Hum Gene Ther
; 13(13): 1611-20, 2002 Sep 01.
Article
in English
| MEDLINE | ID: mdl-12228016
7.
Phase I study of cabazitaxel plus cisplatin in patients with advanced solid tumors: study to evaluate the impact of cytochrome P450 3A inhibitors (aprepitant, ketoconazole) or inducers (rifampin) on the pharmacokinetics of cabazitaxel.
Cancer Chemother Pharmacol
; 74(6): 1113-24, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25307552
Results
1 -
7
de 7
1
Next >
>>